Bladder dysfunction in human T cell lymphotropic virus infection: A prospective cohort study.
José Abraão Carneiro Neto1, Cássius José Vitor de Oliveira1, Sheila Nunes Ferraz1
1Post Graduate Program of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil.
Plos Neglected Tropical Diseases
|January 14, 2022
Summary
Patients with possible human T cell lymphotropic virus type 1-associated myelopathy (HAM) experience less severe bladder dysfunction and slower progression than those with definite HAM. Both groups showed similar bladder issues over time, but definite HAM patients progressed faster to needing catheterization.
Area of Science:
- Neurology
- Infectious Diseases
- Urology
Background:
- Bladder dysfunction is common in human T cell lymphotropic virus type 1-associated myelopathy (HAM).
- Patients with possible or probable HAM/TSP may also exhibit bladder dysfunction, but their progression is less understood.
- This study compares bladder dysfunction severity and progression in possible versus definite HAM/TSP.
Purpose of the Study:
- To compare the severity and evolution of bladder dysfunction in HTLV-1-infected patients with possible and definite HAM/TSP.
- To assess differences in urodynamic findings and symptom progression between these groups.
Main Methods:
- A prospective cohort study followed 90 possible HAM/TSP and 84 definite HAM/TSP patients.
- Bladder dysfunction was assessed using bladder diaries, Overactive Bladder Symptom Scores (OABSS), and urodynamic studies.
- Progression was defined by the need for clean intermittent self-catheterization (CIC).
Main Results:
- Definite HAM/TSP patients had worse baseline nocturia, urgency, and OABSS scores.
- Detrusor overactivity was more prevalent in definite HAM/TSP (77.8%) than possible HAM/TSP (58.7%).
- Time to requiring CIC was shorter in definite HAM/TSP (5.5 years) compared to possible HAM/TSP (6.7 years).
Conclusions:
- Patients with possible HAM/TSP exhibit less severe bladder dysfunction at baseline and slower progression than those with definite HAM/TSP.
- Both groups tend to progress towards requiring CIC over time.
- Despite similarities, distinct progression rates highlight differences in disease evolution.


